Latest News for: isth
Edit
Bayer’s Asundexian Demonstrated a Substantial 26% Reduction in Stroke After a Non-Cardioembolic Ischemic Stroke or High-Risk Transient Ischemic Attack, With No Increase in ISTH Major Bleeding Versus Placebo (Bayer AG)
Public Technologies 05 Feb 2026
). The text version of this document is not available ... Disclaimer ... (noodl. 129321193) .
Edit
Bayer’s asundexian demonstrated a substantial 26% reduction in stroke after a non-cardioembolic ischemic stroke or high-risk transient ischemic attack, with no increase in ISTH major bleeding versus placebo (Bayer Corporation)
Public Technologies 05 Feb 2026
There was no increase in ISTH major bleeding, and the bleeding risk was similar to placebo for minor bleeding, hemorrhagic stroke, symptomatic intracranial hemorrhage and fatal bleeding.
Edit
ISTH selects Vancouver to host its 2027 Congress
Canada Newswire 08 Dec 2025
8, 2025 /CNW/ -- The International Society on Thrombosis and Haemostasis (ISTH) announces that its 2027 Congress will be held in the city of Vancouver, Canada, from June 26-30, 2027 ... Learn more at www.isth.org.
- 1